Here Are Some Essential Facts About Keurig Dr Pepper

More and more people are talking about Keurig Dr Pepper over the last few weeks. Is it worth buying the Beverages stock at a price of $36.55? Only time will tell. The information below will give you a basic idea of what this investment may entail:

  • Keurig Dr Pepper has moved 2.3% over the last year, and the S&P 500 logged a change of -19.7%

  • KDP has an average analyst rating of buy and is -10.16% away from its mean target price of $40.69 per share

  • Its trailing earnings per share (Eps) is $1.28

  • Keurig Dr Pepper has a trailing 12 month Price to Earnings (P/E) ratio of 28.6 while the S&P 500 average is 15.97

  • Its forward P/E ratio is 19.9

  • The company has a Price to Book (P/B) ratio of 2.1 in contrast to the S&P 500's average ratio of 2.95

  • Keurig Dr Pepper is part of the Consumer Defensive sector, which has an average P/E ratio of 24.21 and an average P/B of 4.09

  • KDP has reported YOY quarterly earnings growth of -65.6% and gross profit margins of 52.1%

  • The company has a free cash flow of $2,230,000,128.00, which refers to the total sum of all its inflows and outflows of cash over the last quarter

  • Keurig Dr Pepper Inc. operates as a beverage company in the United States and internationally. Keurig Dr Pepper Inc. was founded in 1981 and is headquartered in Burlington, Massachusetts.

At Market Interference, we believe in giving retail investors access to timely and accurate data to help inform their investment decisions. subscribe to our free newsletter today to keep track of each day's market movers!

The above analysis is intended for educational purposes only and was performed on the basis of publicly available data. It is not to be construed as a recommendation to buy or sell any security. Any buy, sell, or other recommendations mentioned in the article are direct quotations of consensus recommendations from the analysts covering the stock, and do not represent the opinions of Market Inference or its writers. Past performance, accounting data, and inferences about market position and corporate valuation are not reliable indicators of future price movements. Market Inference does not provide financial advice. Investors should conduct their own review and analysis of any company of interest before making an investment decision.